Researcher profile

Steve Yadlowsky

Steve Yadlowsky contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 21 - EmergingVerification L1Unclaimed author
9works
0followers
5topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

9 published item(s)

preprint2022arXiv

Boosting the interpretability of clinical risk scores with intervention predictions

Machine learning systems show significant promise for forecasting patient adverse events via risk scores. However, these risk scores implicitly encode assumptions about future interventions that the patient is likely to receive, based on the intervention policy present in the training data. Without this important context, predictions from such systems are less interpretable for clinicians. We propose a joint model of intervention policy and adverse event risk as a means to explicitly communicate the model's assumptions about future interventions. We develop such an intervention policy model on MIMIC-III, a real world de-identified ICU dataset, and discuss some use cases that highlight the utility of this approach. We show how combining typical risk scores, such as the likelihood of mortality, with future intervention probability scores leads to more interpretable clinical predictions.

preprint2022arXiv

Bounds on the conditional and average treatment effect with unobserved confounding factors

For observational studies, we study the sensitivity of causal inference when treatment assignments may depend on unobserved confounders. We develop a loss minimization approach for estimating bounds on the conditional average treatment effect (CATE) when unobserved confounders have a bounded effect on the odds ratio of treatment selection. Our approach is scalable and allows flexible use of model classes in estimation, including nonparametric and black-box machine learning methods. Based on these bounds for the CATE, we propose a sensitivity analysis for the average treatment effect (ATE). Our semi-parametric estimator extends/bounds the augmented inverse propensity weighted (AIPW) estimator for the ATE under bounded unobserved confounding. By constructing a Neyman orthogonal score, our estimator of the bound for the ATE is a regular root-$n$ estimator so long as the nuisance parameters are estimated at the $o_p(n^{-1/4})$ rate. We complement our methodology with optimality results showing that our proposed bounds are tight in certain cases. We demonstrate our method on simulated and real data examples, and show accurate coverage of our confidence intervals in practical finite sample regimes with rich covariate information.

preprint2022arXiv

Calibration Error for Heterogeneous Treatment Effects

Recently, many researchers have advanced data-driven methods for modeling heterogeneous treatment effects (HTEs). Even still, estimation of HTEs is a difficult task -- these methods frequently over- or under-estimate the treatment effects, leading to poor calibration of the resulting models. However, while many methods exist for evaluating the calibration of prediction and classification models, formal approaches to assess the calibration of HTE models are limited to the calibration slope. In this paper, we define an analogue of the \smash{($\ell_2$)} expected calibration error for HTEs, and propose a robust estimator. Our approach is motivated by doubly robust treatment effect estimators, making it unbiased, and resilient to confounding, overfitting, and high-dimensionality issues. Furthermore, our method is straightforward to adapt to many structures under which treatment effects can be identified, including randomized trials, observational studies, and survival analysis. We illustrate how to use our proposed metric to evaluate the calibration of learned HTE models through the application to the CRITEO-UPLIFT Trial.

preprint2022arXiv

Deep Cox Mixtures for Survival Regression

Survival analysis is a challenging variation of regression modeling because of the presence of censoring, where the outcome measurement is only partially known, due to, for example, loss to follow up. Such problems come up frequently in medical applications, making survival analysis a key endeavor in biostatistics and machine learning for healthcare, with Cox regression models being amongst the most commonly employed models. We describe a new approach for survival analysis regression models, based on learning mixtures of Cox regressions to model individual survival distributions. We propose an approximation to the Expectation Maximization algorithm for this model that does hard assignments to mixture groups to make optimization efficient. In each group assignment, we fit the hazard ratios within each group using deep neural networks, and the baseline hazard for each mixture component non-parametrically. We perform experiments on multiple real world datasets, and look at the mortality rates of patients across ethnicity and gender. We emphasize the importance of calibration in healthcare settings and demonstrate that our approach outperforms classical and modern survival analysis baselines, both in terms of discriminative performance and calibration, with large gains in performance on the minority demographics.

preprint2022arXiv

Explaining Practical Differences Between Treatment Effect Estimators with High Dimensional Asymptotics

We revisit the classical causal inference problem of estimating the average treatment effect in the presence of fully observed confounding variables using two-stage semiparametric methods. In existing theoretical studies of methods such as G-computation, inverse propensity weighting (IPW), and two common doubly robust estimators -- augmented IPW (AIPW) and targeted maximum likelihood estimation (TMLE) -- they are either bias-dominated, or have similar asymptotic statistical properties. However, when applied to real datasets, they often appear to have notably different variance. We compare these methods when using a machine learning (ML) model to estimate the nuisance parameters of the semiparametric model, and highlight some of the important differences. When the outcome model estimates have little bias, which is common among some key ML models, G-computation and the TMLE outperforms the other estimators in both bias and variance. We show that the differences can be explained using high-dimensional statistical theory, where the number of confounders $d$ is of the same order as the sample size $n$. To make this theoretical problem tractable, we posit a generalized linear model for the effect of the confounders on the treatment assignment and outcomes. Despite making parametric assumptions, this setting is a useful surrogate for some machine learning methods used to adjust for confounding in two-stage semiparametric methods. In particular, the estimation of the first stage adds variance that does not vanish, forcing us to confront terms in the asymptotic expansion that normally are brushed aside as finite sample defects. However, our model emphasizes differences in performance between these estimators beyond first-order asymptotics.

preprint2022arXiv

The MultiBERTs: BERT Reproductions for Robustness Analysis

Experiments with pre-trained models such as BERT are often based on a single checkpoint. While the conclusions drawn apply to the artifact tested in the experiment (i.e., the particular instance of the model), it is not always clear whether they hold for the more general procedure which includes the architecture, training data, initialization scheme, and loss function. Recent work has shown that repeating the pre-training process can lead to substantially different performance, suggesting that an alternate strategy is needed to make principled statements about procedures. To enable researchers to draw more robust conclusions, we introduce the MultiBERTs, a set of 25 BERT-Base checkpoints, trained with similar hyper-parameters as the original BERT model but differing in random weight initialization and shuffling of training data. We also define the Multi-Bootstrap, a non-parametric bootstrap method for statistical inference designed for settings where there are multiple pre-trained models and limited test data. To illustrate our approach, we present a case study of gender bias in coreference resolution, in which the Multi-Bootstrap lets us measure effects that may not be detected with a single checkpoint. We release our models and statistical library along with an additional set of 140 intermediate checkpoints captured during pre-training to facilitate research on learning dynamics.

preprint2022arXiv

Using public clinical trial reports to evaluate observational study methods

Observational studies are valuable for estimating the effects of various medical interventions, but are notoriously difficult to evaluate because the methods used in observational studies require many untestable assumptions. This lack of verifiability makes it difficult both to compare different observational study methods and to trust the results of any particular observational study. In this work, we propose TrialVerify, a new approach for evaluating observational study methods based on ground truth sourced from clinical trial reports. We process trial reports into a denoised collection of known causal relationships that can then be used to estimate the precision and recall of various observational study methods. We then use TrialVerify to evaluate multiple observational study methods in terms of their ability to identify the known causal relationships from a large national insurance claims dataset. We found that inverse propensity score weighting is an effective approach for accurately reproducing known causal relationships and outperforms other observational study methods. TrialVerify is made freely available for others to evaluate observational study methods.

preprint2020arXiv

Estimation and Validation of Ratio-based Conditional Average Treatment Effects Using Observational Data

While sample sizes in randomized clinical trials are large enough to estimate the average treatment effect well, they are often insufficient for estimation of treatment-covariate interactions critical to studying data-driven precision medicine. Observational data from real world practice may play an important role in alleviating this problem. One common approach in trials is to predict the outcome of interest with separate regression models in each treatment arm, and estimate the treatment effect based on the contrast of the predictions. Unfortunately, this simple approach may induce spurious treatment-covariate interaction in observational studies when the regression model is misspecified. Motivated by the need of modeling the number of relapses in multiple sclerosis patients, where the ratio of relapse rates is a natural choice of the treatment effect, we propose to estimate the conditional average treatment effect (CATE) as the ratio of expected potential outcomes, and derive a doubly robust estimator of this CATE in a semiparametric model of treatment-covariate interactions. We also provide a validation procedure to check the quality of the estimator on an independent sample. We conduct simulations to demonstrate the finite sample performance of the proposed methods, and illustrate their advantages on real data by examining the treatment effect of dimethyl fumarate compared to teriflunomide in multiple sclerosis patients.

preprint2020arXiv

Off-policy Policy Evaluation For Sequential Decisions Under Unobserved Confounding

When observed decisions depend only on observed features, off-policy policy evaluation (OPE) methods for sequential decision making problems can estimate the performance of evaluation policies before deploying them. This assumption is frequently violated due to unobserved confounders, unrecorded variables that impact both the decisions and their outcomes. We assess robustness of OPE methods under unobserved confounding by developing worst-case bounds on the performance of an evaluation policy. When unobserved confounders can affect every decision in an episode, we demonstrate that even small amounts of per-decision confounding can heavily bias OPE methods. Fortunately, in a number of important settings found in healthcare, policy-making, operations, and technology, unobserved confounders may primarily affect only one of the many decisions made. Under this less pessimistic model of one-decision confounding, we propose an efficient loss-minimization-based procedure for computing worst-case bounds, and prove its statistical consistency. On two simulated healthcare examples---management of sepsis patients and developmental interventions for autistic children---where this is a reasonable model of confounding, we demonstrate that our method invalidates non-robust results and provides meaningful certificates of robustness, allowing reliable selection of policies even under unobserved confounding.